Clinical trial
The Use of Non-invasive Transcutaneous Auricular Neurostimulation (tAN®) in Alcohol Withdrawal Management
NCT06771037 is registered in ClinicalTrials.gov with Erin Takemoto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Non-invasive Transcutaneous Auricular Neurostimulation (tAN®) in Alcohol Withdrawal Management
- Lead sponsor
- Erin Takemoto
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 21, 2025
- Completion date
- December 15, 2025
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol withdrawal